INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 143 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $11,854,000 | +26.3% | 2,565,663 | -4.3% | 0.00% | – |
Q4 2018 | $9,382,000 | -65.7% | 2,680,598 | -1.1% | 0.00% | -100.0% |
Q3 2018 | $27,325,000 | +43.1% | 2,710,787 | +2.8% | 0.00% | 0.0% |
Q2 2018 | $19,096,000 | +29.4% | 2,637,505 | +7.9% | 0.00% | 0.0% |
Q1 2018 | $14,762,000 | -40.1% | 2,443,765 | -4.6% | 0.00% | 0.0% |
Q4 2017 | $24,649,000 | +2.0% | 2,562,445 | -5.8% | 0.00% | 0.0% |
Q3 2017 | $24,165,000 | -27.9% | 2,721,488 | +2.7% | 0.00% | -50.0% |
Q2 2017 | $33,519,000 | +21.1% | 2,649,669 | +0.6% | 0.00% | 0.0% |
Q1 2017 | $27,674,000 | +7875.2% | 2,633,158 | +6904.9% | 0.00% | – |
Q4 2016 | $347,000 | -47.1% | 37,590 | -32.5% | 0.00% | -100.0% |
Q3 2016 | $656,000 | +12.3% | 55,675 | +23.4% | 0.00% | 0.0% |
Q2 2016 | $584,000 | -15.0% | 45,105 | +5.1% | 0.00% | 0.0% |
Q1 2016 | $687,000 | -56.6% | 42,918 | -22.4% | 0.00% | -50.0% |
Q4 2015 | $1,583,000 | +13091.7% | 55,272 | +13060.0% | 0.00% | – |
Q3 2015 | $12,000 | -20.0% | 420 | 0.0% | 0.00% | – |
Q2 2015 | $15,000 | +7.1% | 420 | +74.3% | 0.00% | – |
Q1 2015 | $14,000 | +40.0% | 241 | 0.0% | 0.00% | – |
Q4 2014 | $10,000 | +11.1% | 241 | 0.0% | 0.00% | – |
Q3 2014 | $9,000 | +12.5% | 241 | 0.0% | 0.00% | – |
Q2 2014 | $8,000 | 0.0% | 241 | +27.5% | 0.00% | – |
Q1 2014 | $8,000 | +60.0% | 189 | +50.0% | 0.00% | – |
Q4 2013 | $5,000 | +25.0% | 126 | 0.0% | 0.00% | – |
Q3 2013 | $4,000 | +100.0% | 126 | 0.0% | 0.00% | – |
Q2 2013 | $2,000 | – | 126 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |